Bastion Therapeutics is a preclinical stage biotechnology company with a mission to develop novel Treg therapies to address the unmet clinical need for inflammatory disorders. 

We leverage our proprietary GRIT™ platform technology to enhance Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg therapies. 

Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. 

Biotechnology

Bastion Therapeutics

Org chart

Similar companies